Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Assets: 2012-2025

Historic Return on Assets for CorMedix (CRMD) over the last 9 years, with Sep 2025 value amounting to 0.32%.

  • CorMedix's Return on Assets rose 93.00% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year increase of 93.00%. This contributed to the annual value of -0.45% for FY2022, which is 2.00% up from last year.
  • As of Q3 2025, CorMedix's Return on Assets stood at 0.32%, which was up 26.44% from 0.26% recorded in Q2 2025.
  • In the past 5 years, CorMedix's Return on Assets registered a high of 0.32% during Q3 2025, and its lowest value of -0.79% during Q2 2024.
  • Moreover, its 3-year median value for Return on Assets was -0.54% (2023), whereas its average is -0.32%.
  • As far as peak fluctuations go, CorMedix's Return on Assets fell by 18bps in 2023, and later soared by 105bps in 2025.
  • Over the past 5 years, CorMedix's Return on Assets (Quarterly) stood at -0.43% in 2021, then declined by 4bps to -0.47% in 2022, then decreased by 9bps to -0.54% in 2023, then decreased by 7bps to -0.18% in 2024, then surged by 93bps to 0.32% in 2025.
  • Its last three reported values are 0.32% in Q3 2025, 0.26% for Q2 2025, and 0.13% during Q1 2025.